NCT07034300 Lidocaine vs. Lidocaine With Dexmedetomidine for Intravenous Regional Anesthesia (IVRA) in Upper Limb Surgery
| NCT ID | NCT07034300 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Fatima Memorial Hospital |
| Condition | Post-operative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-05-21 |
| Primary Completion | 2025-08-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 90 participants in total. It began in 2025-05-21 with a primary completion date of 2025-08-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study compares lidocaine alone vs. lidocaine with dexmedetomidine in Intravenous regional anesthesia (IVRA) for upper limb surgery in terms of pain scores and duration of analgesia
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiology Status I * American Society of Anesthesiology Status II * Elective surgery * Surgery duration \<45 minutes Exclusion Criteria: * Sleep apnea * BMI \>30 * Heart block * uncontrolled hypertension
Contact & Investigator
Muhammad M Younas, MBBS
PRINCIPAL INVESTIGATOR
Fatima Memorial Hospital
Frequently Asked Questions
Who can join the NCT07034300 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Post-operative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07034300 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07034300 currently recruiting?
Yes, NCT07034300 is actively recruiting participants. Contact the research team at mansoor.gujjar344@gmail.com for enrollment information.
Where is the NCT07034300 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07034300 clinical trial?
NCT07034300 is sponsored by Fatima Memorial Hospital. The principal investigator is Muhammad M Younas, MBBS at Fatima Memorial Hospital. The trial plans to enroll 90 participants.